Selective glycosidase inhibitors and uses thereof

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 207/12 (2006.01) A61K 31/40 (2006.01) C12Q 1/40 (2006.01)

Patent

CA 2737267

The application relates to an immoalditol compound for selectively inhibiting glycosidases, a prodrug thereof and a pharmaceutical composition comprising the compound or the prodrug The application also relates to the use of the immoalditol compound for treating diseases and disorders related to deficiency or overexpression of O-GlcNAcase, accumulation or deficiency of O-GlcNAc Such diseases and disorders include neurodegenerative diseases, tauopathy, cancers, and cardiac disorders

La présente invention concerne un composé immoalditol destiné à inhiber sélectivement des glycosidases, un promédicament de celui-ci et une composition pharmaceutique comprenant le composé ou le promédicament. L'invention concerne également l'utilisation du composé immoalditol pour traiter des maladies et des troubles liés au manque ou à la surexpression de la O-GlcNAcase, l'accumulation ou la manque de O-GlcNAc. Les maladies et troubles de ce type comprennent les maladies neurodégénératives, les tauopathies, les cancers et les troubles cardiaques.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Selective glycosidase inhibitors and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Selective glycosidase inhibitors and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Selective glycosidase inhibitors and uses thereof will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1987423

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.